טוען...
Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
Vilazodone is a potent selective serotonin reuptake inhibitor and serotonin 1A receptor partial agonist approved for the treatment of major depressive disorder in adults. To assess the efficacy of vilazodone across a range of symptoms and severities of depression, data from two phase III, 8-week, ra...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams And Wilkins
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3901802/ https://ncbi.nlm.nih.gov/pubmed/24247740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000016 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|